Dr. Ing. h.c. F. Porsche AG P911.DE
Composite 39/100; the shares have moved about 29% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 8/100 — a strong mark against it.
Balance-sheet strength ranks 61/100 — a slight point in its favour.
Growth ranks 8/100 — a strong mark against it. Quality ranks 28/100 — a moderate mark against it. Income ranks 36/100 — a moderate mark against it.
What the company does Dr. Ing. h.c. F. Porsche AG designs, manufactures, and sells luxury vehicles and related financial services globally, including leasing, financing, and mobility solutions under the Porsche brand.
Key financials Porsche’s trailing P/E is 132x, forward P/E 25x, and EV/EBITDA 7.28x. Margins: gross 14.1%, operating 7.1%, net 0.9%. ROE 0.8%, ROA 0.7%, ROCE 0.9%. Debt/equity 0.29, current ratio 1.44. Dividend yield 2.3%, payout 109.8%.
Stock health Sideravia scores Porsche “Poor quality, fairly valued.” Quality 23.5, Growth 21.9, Strength 70.6, Valuation 64.4, Momentum 51.8, Income 44.6. RSI(14) 45.80; down 11% from 52-week high.
Price vs fair value The stock trades at a discount of 6.80% versus our fair-value estimate and a discount of 3.93% versus the 12-month target. - Profit rose 34% despite 5% revenue decline (GuruFocus.com) - Turnaround efforts starting to pay off (The Wall Street Journal) - Luxury brands cite China consumer weakness (Yahoo Finance Video) - Guidance confirmed as turnaround gains traction (The Wall Street Journal)
Looking forward Forward P/E of 25x and PEG of 0.06 imply earnings recovery expectations. Analysts see 21.0 targets averaging 45.94, suggesting limited upside from current levels. Execution on cost cuts and China strategy will be key.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.